Loperamide hydrochloride
Brand names: Imodium
Loperamide hydrochloride is an antimotility agent used for the symptomatic relief of acute and chronic diarrhoea.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a peripherally acting opioid receptor agonist in the gut wall that slows intestinal motility and increases transit time, allowing greater absorption of fluid and electrolytes, with negligible central effects at normal doses.
Prescribing in practice
- Avoid in acute diarrhoea where reducing motility is hazardous, including suspected bacterial colitis, dysentery with blood and fever, and active ulcerative colitis flares where it can precipitate toxic megacolon.
- Serious cardiac events including QT prolongation and arrhythmia have been reported with overdose, so it must not be exceeded and is liable to misuse.
- It should not be used as the sole treatment in young children and is not a substitute for rehydration in infective diarrhoea.
Monitoring
No routine monitoring is required for short-term use; review if diarrhoea persists, worsens, or is accompanied by blood, fever or abdominal distension.
Counselling the patient
- Take plenty of fluids to replace what is lost; this medicine treats the symptom but not the cause.
- Stop and seek advice if you develop a high fever, blood in the stool, or marked abdominal swelling, and never exceed the stated dose.
Evidence & guidelines
Loperamide is a widely established first-line antimotility treatment for symptomatic relief of uncomplicated diarrhoea.
Reference: NICE CKS; MHRA Drug Safety Update; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Morphine Milligram Equivalents (MME) Calculator · Pain / Opioids
- Opioid Conversion / Equianalgesic Guide · Pain Management
- Numeric Rating Scale (NRS) Pain Assessment and Management · Pain Management
- Finnegan Neonatal Abstinence Scoring Tool (FNAST) · Neonatal Abstinence Syndrome
- Modified Finnegan Neonatal Abstinence Score (NAS) · Neonatal
- Withdrawal Assessment Tool (WAT-1) for Paediatric Iatrogenic Withdrawal · Critical Care
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021